EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) increased its quarterly dividend by 18% to 26 cents per share, extending the Exton-based drug delivery manufacturer’s streak of annual dividend increases to 34 consecutive years.
The company’s board approved the fourth-quarter dividend on October 19, raising the payment from 22 cents per share in the previous quarter.
The dividend is payable November 18, 2026, to shareholders of record as of November 11.
At the new rate, West’s annualized dividend rises to $1.04 per share from 88 cents, assuming the quarterly payment remains unchanged.
The increase represents an additional 16 cents per share in annualized distributions, reinforcing the company’s longstanding practice of returning capital to shareholders through dividends.
West manufactures components and devices used in the containment and administration of injectable medicines, supplying pharmaceutical and biotechnology companies worldwide.
The company reported $3.07 billion in net sales for fiscal 2025 and operates 50 facilities globally, including 26 manufacturing sites.
West employs more than 10,000 people and supplies more than 41 billion components and devices annually, supporting drug manufacturers across established and emerging therapeutic markets.
Headquartered in Exton, West is listed on the New York Stock Exchange and is a constituent of the S&P 500 Index.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.